AzTrials
AzTrials

Individual SatisfactionNCT05514262

The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination

A study testing The stress ball and The Buzzy® device in people with Individual Satisfaction and Pain Management, run by Uludag University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study was to determine the effect on pain and satisfaction during the administration of Covid-19 vaccination of two different non-pharmacological methods: squeezing a stress ball and placing Buzzy® on the injection site. Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Individual Satisfaction, Pain Management
What is being tested?
The stress ball and The Buzzy® device
Type of treatment
Vaccines, Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
No sites listed yet
Study dates
30 Aug 2022to 30 Nov 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Approving the Pfizer-BioNTech vaccination from the Turkish Ministry of Health
  • Not having had an injection or vaccination in the deltoid muscle for at least three months
  • Participating voluntarily in the study
  • Being able to speak and understand Turkish
  • Being aged 18 years or older
  • Not having any vision or auditory problems
  • Not having any condition which might affect pain sensation
  • Not having developed any complication which would hinder a delta muscle injection.

Who cannot join

  • Not wanting to participate in the study, or during the course of the research, wishing to withdraw from the study
  • Having any condition which would affect the sensation of pain
  • Not being able to agree on a place or time
  • Being less than 18 years of age

Trial locations and contacts

No sites are listed yet.

Dilek Yılmaz, PhD contact

+905073580330

dilekk@uludag.edu.tr

Münevver Kutlu, BN contact

+905079037634

201910003@ogr.uludag.edu.tr

About this study

The aim of this study was to determine the effect on pain and satisfaction during the administration of Covid-19 vaccination of two different non-pharmacological methods: squeezing a stress ball and placing Buzzy® on the injection site.

The research was planned with a prospective, randomized controlled and experimental design. Data collection will take place at the Covid-19 Vaccination Clinic of the Health Research and Application Center of Bursa Uludağ University. The research sample will consist of individuals who on the date of the beginning of the data collection stage asked for or approved the Pfizer-BioNTech vaccination for themselves from the Turkish Ministry of Health, and who agreed to participate in the research.

Read more

The size of the study sample was statistically determined with the program G*Power 3.1.7. As a result of power analysis, the total minimum sample width was calculated as 120 people, with 40 in each group, accepting type I error level as 5% and in order to achieve an 80% power level. Individuals who meet the research criteria will be assigned to the implementation and control groups by means of a randomization list created by computer according to age and gender.

Research data will be collected face to face, using an Individual Description Form, a Visual Comparison Scale and a Visual Individual Satisfaction Scale.

The following interventions will be performed on the individuals in the intervention group in addition to the standard vaccination procedure:

Covid-19 vaccination procedure with individuals in the stress ball group: With this group, a yellow stress ball will be used which is 6cm in diameter, of medium hardness and made of high quality silicone, and which returns to its original shape after being squeezed. The researcher will explain to the individuals in the group how they should use the stress ball five minutes before beginning the vaccination and during the procedure. The individuals will be taught to take the stress ball in their right hand, the side on which the vaccination will not be given, and, counting from one to three, to squeeze and release the ball, continuing until the procedure is finished. It will be explained that during the procedure, they should give their attention to the stress ball and focus on squeezing it.

Covid-19 vaccination procedure with individuals in the Buzzy® group: Individuals in this group will use the Buzzy® device. Before the vaccination procedure, the researcher will place the Buzzy® device, which will be at room temperature, on the vaccination site, and it will vibrate in a non-discomforting way for one minute. After this, the Buzzy® device will be removed from the site, and the nurse will perform the vaccination. Because Buzzy® is a device which can be re-used, it will be disinfected after each vaccination procedure, and re-used with other individuals. The Buzzy® device also has ice wings which will not be used in this study, and only the body of the device will be used to provide vibration.

Covid-19 vaccination procedure with individuals in the control group: Individuals included in the control group will receive no intervention before the vaccination procedure, and the routine Covid-19 vaccination procedure will be used.

Immediately after the administration of the vaccination, an assistant researcher who is unaware of the injection method used will ask individuals from all groups to assess their pain levels with the Visual Comparison Scale and their satisfaction with the procedure by means of the Visual Individual Satisfaction Scale, and the scores will be recorded on the data collection forms.

Read the detailed description

The aim of this study was to determine the effect on pain and satisfaction during the administration of Covid-19 vaccination of two different non-pharmacological methods: squeezing a stress ball and placing Buzzy® on the injection site.

The research was planned with a prospective, randomized controlled and experimental design. Data collection will take place at the Covid-19 Vaccination Clinic of the Health Research and Application Center of Bursa Uludağ University. The research sample will consist of individuals who on the date of the beginning of the data collection stage asked for or approved the Pfizer-BioNTech vaccination for themselves from the Turkish Ministry of Health, and who agreed to participate in the research.

The size of the study sample was statistically determined with the program G*Power 3.1.7. As a result of power analysis, the total minimum sample width was calculated as 120 people, with 40 in each group, accepting type I error level as 5% and in order to achieve an 80% power level. Individuals who meet the research criteria will be assigned to the implementation and control groups by means of a randomization list created by computer according to age and gender. That is, the group in which the individuals are placed will be determined by a randomization method according to a randomization list created on a computer.

Research data will be collected face to face, using an Individual Description Form, a Visual Comparison Scale and a Visual Individual Satisfaction Scale.

Individual Description Form: This form will contain questions on the individual's age, gender, education level, height, weight, and previous Covid-19 vaccinations.

Visual Comparison Scale (VCS): The VCS is a 10-cm-long scale used to assess pain intensity felt during a procedure. One end represents no pain, and the other end the most severe pain possible. In this study, a vertical scale will be used.

Visual Individual Satisfaction Scale: The individuals' state of satisfaction during the administration of the vaccination will be assessed with the Visual Individual Satisfaction Scale, which consists of a 10-cm vertical line, at one end of which is written "I am very satisfied" and at the other "I am not at all satisfied".

Close attention will be paid to Covid-19 precautions when collecting research data. After confirming the voluntary participation of the individuals, they will be assigned to the intervention and control groups. After that, their descriptive characteristics will be recorded on a data collection form, and then they will be given information on the use of the Visual Comparison Scale and the Visual Individual Satisfaction Scale.

All of the individuals will receive the vaccination with the use of the 1-ml syringes distributed specifically for the vaccinations according to the specifications of the Turkish Ministry of Health. All vaccinations will be given to the deltoid muscle as one dose (0.3ml). It is planned that all vaccinations will be administered by the same nurse working in the Vaccination Unit, with individuals in an appropriate sitting position, into the deltoid muscle of the left upper arm at an angle of 90° and without aspiration. Determination of the deltoid area where the vaccination will be administered will be achieved in this way: an imaginary horizontal line will be drawn on the outside surface of the arm to which the vaccination is to be administered to the end of the humerus; each end of this imaginary line will join in the axillary alignment to form an inverted triangle, and the area in the middle of the triangle will be used as the injection area. The standard vaccination administration procedure steps will be followed for all individuals in the intervention and control groups.

The following interventions will be performed on the individuals in the intervention group in addition to the standard vaccination procedure:

Covid-19 vaccination procedure with individuals in the stress ball group: With this group, a yellow stress ball will be used which is 6cm in diameter, of medium hardness and made of high quality silicone, and which returns to its original shape after being squeezed. The researcher will explain to the individuals in the group how they should use the stress ball five minutes before beginning the vaccination and during the procedure. The individuals will be taught to take the stress ball in their right hand, the side on which the vaccination will not be given, and, counting from one to three, to squeeze and release the ball, continuing until the procedure is finished. It will be explained that during the procedure, they should give their attention to the stress ball and focus on squeezing it.

Covid-19 vaccination procedure with individuals in the Buzzy® group: Individuals in this group will use the Buzzy® device. Before the vaccination procedure, the researcher will place the Buzzy® device, which will be at room temperature, on the vaccination site, and it will vibrate in a non-discomforting way for one minute. After this, the Buzzy® device will be removed from the site, and the nurse will perform the vaccination. Because Buzzy® is a device which can be re-used, it will be disinfected after each vaccination procedure, and re-used with other individuals. The Buzzy® device also has ice wings which will not be used in this study, and only the body of the device will be used to provide vibration.

Covid-19 vaccination procedure with individuals in the control group: Individuals included in the control group will receive no intervention before the vaccination procedure, and the routine Covid-19 vaccination procedure will be used.

Immediately after the administration of the vaccination, an assistant researcher who is unaware of the injection method used will ask individuals from all groups to assess their pain levels with the Visual Comparison Scale and their satisfaction with the procedure by means of the Visual Individual Satisfaction Scale, and the scores will be recorded on the data collection forms.

Being tested
The stress ball, The Buzzy® device
Keywords
covid-19, covid-19 vaccine, pain control, nonpharmacological method, satisfaction
Medical subject headings
Agnosia, COVID-19, Personal Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The stress ballOther

    Covid-19 vaccination procedure with individuals in the stress ball group: With this group, a yellow stress ball will be used which is 6cm in diameter, of medium hardness and made of high quality silicone, and which returns to its original shape after being squeezed. The researcher will explain to the individuals in the group how they should use the stress ball five minutes before beginning the vaccination and during the procedure. The individuals will be taught to take the stress ball in their right hand, the side on which the vaccination will not be given, and, counting from one to three, to squeeze and release the ball, continuing until the procedure is finished. It will be explained that during the procedure, they should give their attention to the stress ball and focus on squeezing it.

  • The Buzzy® deviceDevice

    Covid-19 vaccination procedure with individuals in the Buzzy® group: Individuals in this group will use the Buzzy® device. Before the vaccination procedure, the researcher will place the Buzzy® device, which will be at room temperature, on the vaccination site, and it will vibrate in a non-discomforting way for one minute. After this, the Buzzy® device will be removed from the site, and the nurse will perform the vaccination. Because Buzzy® is a device which can be re-used, it will be disinfected after each vaccination procedure, and re-used with other individuals. The Buzzy® device also has ice wings which will not be used in this study, and only the body of the device will be used to provide vibration.

Study groups in NCT05514262
Study groupRoleWhat they receive
The stress ball groupExperimentalWith this group, a yellow stress ball will be used which is 6cm in diameter, of medium hardness and made of high quality silicone, and which returns to its original shape after being squeezed. The researcher will explain to the individuals in the group how they should use the stress ball five minutes before beginning the vaccination and during the procedure. The individuals will be taught to take the stress ball in their right hand, the side on which the vaccination will not be given, and, counting from one to three, to squeeze and release the ball, continuing until the procedure is finished. It will be explained that during the procedure, they should give their attention to the stress ball and focus on squeezing it.
Receives: Other: The stress ball
The Buzzy® groupExperimentalIndividuals in this group will use the Buzzy® device. Before the vaccination procedure, the researcher will place the Buzzy® device, which will be at room temperature, on the vaccination site, and it will vibrate in a non-discomforting way for one minute. After this, the Buzzy® device will be removed from the site, and the nurse will perform the vaccination. Because Buzzy® is a device which can be re-used, it will be disinfected after each vaccination procedure, and re-used with other individuals. The Buzzy® device also has ice wings which will not be used in this study, and only the body of the device will be used to provide vibration.
Receives: Device: The Buzzy® device
The control groupNo interventionIndividuals included in the control group will receive no intervention before the vaccination procedure, and the routine Covid-19 vaccination procedure will be used.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary Outcome Measure-1

    pain intensity in mm

    Measured: 4 months

  2. Primary Outcome Measure-2

    the individuals' state of satisfaction in mm

    Measured: 4 months

Secondary outcomes (3)
  1. Secondary Outcome Measure-1

    weight in kilograms

    Measured: 4 months

  2. Secondary Outcome Measure-2

    height in meters

    Measured: 4 months

  3. Secondary Outcome Measure-3

    BMI in kg/m^2

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2022
  2. Study start30 Aug 2022 (estimated)
  3. Primary completion15 Nov 2022 (estimated)
  4. Study completion30 Nov 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05514262
Sponsor's protocol ID
2022/15-2
Status last verified
Aug 2022
First submitted
21 Aug 2022
Last updated
24 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing The stress ball and The Buzzy® device in people with Individual Satisfaction and Pain Management, run by Uludag University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dilek Yılmaz, PhD (+905073580330, dilekk@uludag.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary Outcome Measure-1 (time frame: 4 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in